JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2003; 41:539-545, doi:10.1016/S0735-1097(02)02866-8
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koide, S.-i.
Right arrow Articles by Ogawa, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koide, S.-i.
Right arrow Articles by Ogawa, H.

Association of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarction

Shun-ichi Koide, MD*, Kiyotaka Kugiyama, MD, PhD*{dagger},*, Seigo Sugiyama, MD, PhD*, Shin-ichi Nakamura, MD*, Hironobu Fukushima, MD*, Osamu Honda, MD*, Michihiro Yoshimura, MD, PhD* and Hisao Ogawa, MD, PhD*

* Department of Cardiovascular Medicine, Kumamoto University School of Medicine, Kumamoto, Japan
{dagger} Second Department of Internal Medicine, Yamanashi University School of Medicine, Yamanashi, Japan



View larger version (53K):

[in a new window]
 
Figure 1 Ethidium bromide gel showing three genotypes from a single nucleotide polymorphism (C or T) in the promoter region 129 bases upstream of the GCLC gene. The 613-bp polymerase chain reaction amplification fragment contains an invariant Tsp45I restriction site, yielding a constant 113-bp fragment seen in all lanes. Individuals homozygous for the C allele have no additional Tsp45I restriction sites and consequently show only two bands: at 500-bp and the invariant band at 113-bp. The –129T allele creates an additional Tsp45I site such that homozygous T-allele individuals have three bands at 302-, 198-, and 113-bp. Heterozygous individuals show all four bands.

 


View larger version (16K):

[in a new window]
 
Figure 2 Percent changes (mean ± SEM) in lumen diameter from baseline in response to acetylcholine in the proximal and distal segments of the left anterior descending coronary arteries in subjects with the –129C/T or T/T genotype (solid bars) (n = 31) and in age-matched subjects with the –129C/C genotype (open bars) (n = 31).

 


View larger version (15K):

[in a new window]
 
Figure 3 Effects of the –129C/T polymorphism on GCLC promoter activity in human umbilical vein endothelial cells. The transfected cells were incubated for 18 h with H2O2 (100 µmol/l) or phosphate-buffered saline (PBS) (as a time control). Promoter activity is expressed as relative luciferase activity normalized to Renilla activity. Data are presented as the mean value ± SEM from eight independent experiments. *p < 0.05, {dagger}p < 0.01. Open bars = –129C; solid bars = –129T.

 


View larger version (69K):

[in a new window]
 
Figure 4 Electrophoretic mobility shift assay: allele-specific binding of nuclear protein to the –129C/T polymorphic site. Nuclear extracts were obtained from human umbilical vein endothelial cells after treatment for the indicated time with H2O2 (100 µmol/l) or phosphate-buffered saline (PBS) (as a time control). Left panel = interaction with the –129C probe; right panel = interaction with the –129T probe.

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2003 by the American College of Cardiology Foundation.